Insys Therapeutics, Inc. 4
4 · Insys Therapeutics, Inc. · Filed May 23, 2016
Insider Transaction Report
Form 4
BAKER DARRYL S
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2016-05-23$13.57/sh+10,000$135,700→ 21,030 total - Exercise/Conversion
Stock Option (right to buy)
2016-05-23−10,000→ 80,000 totalExercise: $13.57Exp: 2024-08-06→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The option was previously reported as an option to purchase 45,000 shares at an exercise price of $27.14 per share, and has been adjusted to reflect the 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
- [F2]The option vests in 48 equal monthly installments and will be fully vested and exercisable on August 7, 2018.
- [F3]On June 5, 2015, the Issuer effected a 2-for-1 forward stock split, resulting in the reporting person's ownership of 45,000 additonal options.